Maria Leo
Nurse Practitioner · Bethesda, MDNPI 1922728443
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.0% of the total across 113 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,498 and has fallen 73.5% since, to $397 in 2025. Among nurse practitioner clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 113 payments — averaging $25.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$456
- Takeda Pharmaceuticals U.S.A., Inc.$363
- Regeneron Healthcare Solutions, Inc.$348
- CSL Behring$209
- Incyte Corporation$188
- AstraZeneca$117
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,74996%
- Education$1154%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 18 | $456 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $363 |
| Regeneron Healthcare Solutions, Inc. | 13 | $348 |
| CSL Behring | 9 | $209 |
| Incyte Corporation | 5 | $188 |
| AstraZeneca(2 entities) | 3 | $117 |
| Merck | 5 | $108 |
| Seagen Inc. | 5 | $103 |
| Grifols USA, LLC | 4 | $98 |
| G1 Therapeutics, Inc. | 3 | $66 |
| Kaleo, Inc. | 2 | $65 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $65 |
| Amgen | 3 | $63 |
| Pharmaessentia USA Corporation | 2 | $57 |
| Sanofi | 1 | $43 |
| Seqirus USA Inc | 2 | $41 |
| AVEO Pharmaceuticals, Inc. | 1 | $40 |
| Lilly USA, LLC | 2 | $39 |
| Cycle Pharmaceuticals Inc | 2 | $38 |
| ADC Therapeutics America, Inc. | 2 | $37 |
| Mirati Therapeutics, Inc. | 1 | $36 |
| Pfizer | 1 | $33 |
| Stemline Therapeutics Inc. | 1 | $27 |
| Ipsen Biopharmaceuticals, Inc | 1 | $25 |
| Pharming Healthcare, Inc. | 1 | $25 |
| Bayer | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Blueprint Medicines Corporation | 1 | $22 |
| EMD Serono, Inc. | 1 | $22 |
| Myriad Genetic Laboratories, Inc. | 1 | $20 |
| Morphosys, US Inc. | 1 | $20 |
| AbbVie | 1 | $15 |
| Acrotech Biopharma Inc. | 1 | $15 |
| Beigene USA, Inc. | 1 | $14 |
How this compares
$2,864 in reported general payments places this provider in the 90th percentile of 1,562 nurse practitioner providers in Maryland.
Other nurse practitioner in Bethesda
- Francesca van SantBethesda$16K
- Diane HearnBethesda$7K
- Elizabeth SmithBethesda$6K
- Susan GranatoBethesda$5K
- Morgan GaleRockville$292K
- Sherilyn BrinkleyBaltimore$100K
- Michelle TurnerBaltimore$94K
- Nelli ZafmanLutherville$67K
- Ellen LancasterFallston$52K
- Doris TateEaston$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.